Andrea Waksmunski

Dr. Andrea Waksmunski

Case Western Reserve University
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2022 in Genes
Verified
Journal Article
Open access
PDF file
JBJessica Cooke Bailey
Jessica Cooke Bailey
KFKaitlyn L. Funk
Kaitlyn L. Funk
LCLauren A. Cruz
Lauren A. Cruz
Andrea WaksmunskiAndrea Waksmunski
Andrea Waksmunski
TKTyler G. Kinzy
Tyler G. Kinzy
MHMichael A. Hauser
Michael A. Hauser
Glaucoma is the leading cause of irreversible blindness worldwide. Primary open-angle glaucoma (POAG), the most common glaucoma subtype, is more prevalent and severe in individuals of African ancestry. Unfortunately, this ancestral group has been historically under-represented among genetic studies of POAG. Moreover, both genetic and polygenic risk scores (GRS, PRS) that are typically based on genetic data from European-descent populations are not transferable to individuals without a majority of European ancestry. Given the aspirations of leveraging genetic information for precision medicine, GRS and PRS demonstrate clinical potential but fall short, in part due to the lack of diversity in these studies. Prioritizing diversity in the discovery of risk variants will improve the performance and utility of GRS and PRS-derived risk estimation for disease stratification, which could bring about earlier POAG intervention and treatment for a disease that often goes undetected until significant damage has occurred.

17 June 2022 in Ophthalmology
Verified
Journal Article
Closed access
Andrea WaksmunskiAndrea Waksmunski
Andrea Waksmunski
TKTyler G. Kinzy
Tyler G. Kinzy
LCLauren A. Cruz
Lauren A. Cruz
CNCari L. Nealon
Cari L. Nealon
CHChristopher W. Halladay
Christopher W. Halladay
RSRobert Striker
Robert Striker

3 September 2019 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
Andrea WaksmunskiAndrea Waksmunski
Andrea Waksmunski
MGMichelle Grunin
Michelle Grunin
TKTyler G. Kinzy
Tyler G. Kinzy
RIRobert P. Igo
Robert P. Igo
JHJonathan L. Haines
Jonathan L. Haines
FCfor the International Age-Related Macular Degeneration Genomics Consortium
for the International Age-Related Macular Degeneration Genomics Consortium
Purpose: Age-related macular degeneration (AMD) is the worldwide leading cause of blindness among the elderly. Although genome-wide association studies (GWAS) have identified AMD risk variants, their roles in disease etiology are not well-characterized, and they only explain a portion of AMD heritability. Methods: We performed pathway analyses using summary statistics from the International AMD Genomics Consortium's 2016 GWAS and multiple pathway databases to identify biological pathways wherein genetic association signals for AMD may be aggregating. We determined which genes contributed most to significant pathway signals across the databases. We characterized these genes by constructing protein-protein interaction networks and performing motif analysis. Results: We determined that eight genes (C2, C3, LIPC, MICA, NOTCH4, PLCG2, PPARA, and RAD51B) “drive” the statistical signals observed across pathways curated in the Kyoto Encyclopedia of Genes and Genomes (KEGG), Reactome, and Gene Ontology (GO) databases. We further refined our definition of statistical driver gene to identify PLCG2 as a candidate gene for AMD due to its significant gene-level signals (P < 0.0001) across KEGG, Reactome, GO, and NetPath pathways. Conclusions: We performed pathway analyses on the largest available collection of advanced AMD cases and controls in the world. Eight genes strongly contributed to significant pathways from the three larger databases, and one gene (PLCG2) was central to significant pathways from all four databases. This is, to our knowledge, the first study to identify PLCG2 as a candidate gene for AMD based solely on genetic burden. Our findings reinforce the utility of integrating in silico genetic and biological pathway data to investigate the genetic architecture of AMD.

Andrea WaksmunskiAndrea Waksmunski
Andrea Waksmunski
YSYeunjoo E. Song
Yeunjoo E. Song
TKTyler G. Kinzy
Tyler G. Kinzy
RLReneé A. Laux
Reneé A. Laux
JSJane Sewell
Jane Sewell
JBJessica Cooke Bailey
Jessica Cooke Bailey
Glaucoma leads to millions of cases of visual impairment and blindness around the world. Its susceptibility is shaped by both environmental and genetic risk factors. Although over 120 risk loci have been identified for glaucoma, a large portion of its heritability is still unexplained. Here we describe the foundation of the Genetics of GLaucoma Evaluation in the AMish (GGLEAM) study to investigate the genetic architecture of glaucoma in the Ohio Amish, which exhibits lower genetic and environmental heterogeneity compared to the general population. To date, we have enrolled 81 Amish individuals in our study from Holmes County, Ohio. As a part of our enrollment process, 62 GGLEAM study participants (42 glaucoma-affected and 20 unaffected individuals) received comprehensive eye examinations and glaucoma evaluations. Using the data from the Anabaptist Genealogy Database, we found that 80 of the GGLEAM study participants were related to one another through a large, multigenerational pedigree containing 1586 people. We plan to integrate the health and kinship data obtained for the GGLEAM study to interrogate glaucoma genetics and pathophysiology in this unique population.

24 November 2022 in Biocomputing 2020
Verified
Conference Paper
Open access
Andrea WaksmunskiAndrea Waksmunski
Andrea Waksmunski
TKTyler G. Kinzy
Tyler G. Kinzy
LCLauren A. Cruz
Lauren A. Cruz
CNCari L. Nealon
Cari L. Nealon
CHChristopher W. Halladay
Christopher W. Halladay
JBJessica N. Cooke Bailey
Jessica N. Cooke Bailey
A major goal of precision medicine is to stratify patients based on their genetic risk for a disease to inform future screening and intervention strategies. For conditions like primary open-angle glaucoma (POAG), the genetic risk architecture is complicated with multiple variants contributing small effects on risk. Following the tepid success of genome-wide association studies for high-effect disease risk variant discovery, genetic risk scores (GRS), which collate effects from multiple genetic variants into a single measure, have shown promise for disease risk stratification. We assessed the application of GRS for POAG risk stratification in Hispanic-descent (HIS) and European-descent (EUR) Veterans in the Million Veteran Program. Unweighted and cross-ancestry meta-weighted GRS were calculated based on 127 genomic variants identified in the most recent report of cross-ancestry POAG meta-analyses. We found that both GRS types were associated with POAG case-control status and performed similarly in HIS and EUR Veterans. This trend was also seen in our subset analysis of HIS Veterans with less than 50% EUR global genetic ancestry. Our findings highlight the importance of evaluating GRS based on known POAG risk variants in different ancestry groups and emphasize the need for more multi-ancestry POAG genetic studies.

27 September 2019
Verified
Book Chapter
Closed access
Andrea WaksmunskiAndrea Waksmunski
Andrea Waksmunski
LMLeighanne R. Main
Leighanne R. Main
JHJonathan L. Haines
Jonathan L. Haines